1. Home
  2. DXCM vs PHG Comparison

DXCM vs PHG Comparison

Compare DXCM & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DexCom Inc.

DXCM

DexCom Inc.

N/A

Current Price

$86.33

Market Cap

34.4B

Sector

Health Care

ML Signal

N/A

Logo Koninklijke Philips N.V. NY Registry Shares

PHG

Koninklijke Philips N.V. NY Registry Shares

N/A

Current Price

$23.78

Market Cap

25.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DXCM
PHG
Founded
1999
1891
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.4B
25.3B
IPO Year
2005
1994

Fundamental Metrics

Financial Performance
Metric
DXCM
PHG
Price
$86.33
$23.78
Analyst Decision
Strong Buy
Hold
Analyst Count
28
5
Target Price
★ $94.48
$32.21
AVG Volume (30 Days)
★ 3.2M
690.5K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
N/A
★ 3.44%
EPS Growth
★ 47.18
N/A
EPS
★ 1.15
N/A
Revenue
N/A
N/A
Revenue This Year
$12.19
$0.48
Revenue Next Year
$10.89
$4.43
P/E Ratio
$75.01
★ $28.46
Revenue Growth
N/A
N/A
52 Week Low
$54.11
$23.85
52 Week High
$92.59
$33.44

Technical Indicators

Market Signals
Indicator
DXCM
PHG
Relative Strength Index (RSI) 52.96 32.73
Support Level $87.51 $23.85
Resistance Level $91.77 $27.25
Average True Range (ATR) 1.95 0.27
MACD -0.21 0.00
Stochastic Oscillator 61.50 2.63

Price Performance

Historical Comparison
DXCM
PHG

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

About PHG Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

Share on Social Networks: